(S1 (S (NP (NP (VBN Degraded) (NN CGN)) (VP (VB Induce) (NP (NP (DT an) (NN Increase)) (PP (IN in) (NP (NP (NP (NN ICAM-1)) (CC and) (NP (NN TNF-alpha))) (NN mRNA) (NN Expression))))))))
(S1 (S (S (NP (NP (DT The) (NN increase)) (PP (IN in) (NP (NP (NN surface) (NN ICAM-1) (NN expression)) (CC and) (NP (NP (NN TNF-alpha) (NN production)) (PP (IN by) (NP (NNS monocytes))))))) (VP (VBD correlated) (PP (IN with) (NP (NP (DT an) (NN upregulation)) (PP (IN of) (NP (NN mRNA))) (PP (IN for) (NP (DT these) (NNS molecules))))))) (. .)))
(S1 (S (S (S (NP (ADJP (CC Both) (ADJP (CD 10) (NN kDa)) (CC and) (ADJP (CD 40) (NN kDa))) (NN dCGN)) (VP (VBD induced) (NP (NP (DT a) (JJ robust) (NN increase)) (PP (IN in) (NP (NP (NN mRNA)) (PP (IN for) (NP (CC both) (NP (NN ICAM-1)) (CC and) (NP (NN TNF-alpha))))))))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 6)) (-RRB- -RRB-)) (. .)) (S (NP (NN beta-actin) (NN mRNA) (NNS levels)) (VP (VBD were) (RB not) (VP (VBN affected) (PP (IN by) (NP (NN dCGN) (NN treatment)))))) (. .)))
